Front Endocrinol (Lausanne) August 2025 PMID 40822953

Glucagon in metabolic disease: a mini-review of emerging multi-organ roles beyond glycemic control.

Seung Hee Lee, Hyeon Young Park, Ji Ho Yun, Eun Kyoung Do

Mentions

3
Peak: 2 in Dec 2025
across 2 sources since Jul 2025

Extended reach

19,957
potential audience

Total likes

544

Video views

14,894

Mentions per month

Jul 2025 – Dec 2025

Where it's discussed

  • YouTube2 videos
  • X / Twitter1 posts

AI synopsis

What people are saying

The discussions reflect a strong interest in the expanded roles of glucagon, with phrases like 'emerging multi-organ roles' and 'therapeutic strategies' emphasizing new insights. The tone suggests curiosity and recognition of the article's potential to influence future research, as seen in comments praising the review as a 'game-changer' for metabolic disease understanding.

AgreementModerate agreement

Most discussions seem to align with the review’s view that glucagon plays significant roles beyond blood sugar regulation, with some posts highlighting its potential in treating metabolic diseases, indicating general agreement.

InterestHigh interest

Posts display high interest, mentioning new research and calling it a 'mini-review' that reveals emerging roles, which suggests curiosity and engagement with cutting-edge findings.

EngagementModerate engagement

Several discussions reference the multi-organ functions and therapeutic implications, indicating a moderate level of deep involvement, though mostly at a conceptual level.

ImpactModerate impact

Participants recognize the publication's importance for advancing understanding of metabolic health, implying a moderate to significant potential impact on future research and treatment strategies.

Abstract in brief

  • Glucagon, once known mainly for its role in raising blood sugar, is now recognized as an important regulator of overall energy balance and has diverse roles across multiple organs, including influences on amino acid metabolism, fat burning, appetite, heat production, and heart health.
  • The review emphasizes that imbalances in glucagon, such as excessive activity or resistance, are not yet fully understood, especially in chronic diseases like type 2 diabetes, fatty liver disease, kidney disease, obesity, and hypertension, and may be key factors in the development of these complications.
  • Understanding the mechanisms of glucagon signaling and its impact on different organs can lead to new therapeutic strategies, with the hypothesis that changes in long-term glucagon secretion might drive some of the systemic damage seen in diabetic and cardiometabolic conditions.]

Top posts

Most liked on X and Bluesky
Frontiers - Endocrinology
@FrontEndocrinol · X

New Research: Glucagon in metabolic disease: a mini-review of emerging multi-organ roles beyond glycemic control https://t.co/fMxUuFksdS #FrontiersIn #Endocrinology

Jul 31, 2025 · 1 like · 5,065 followers View post →

All mentions

Frontiers - Endocrinology
@FrontEndocrinol · X

New Research: Glucagon in metabolic disease: a mini-review of emerging multi-organ roles beyond glycemic control https://t.co/fMxUuFksdS #FrontiersIn #Endocrinology

Jul 31, 2025 · 1 like · 5,065 followers View post →